Lentiviruses are nononcogenic retroviruses that cause persistent infections and slowly progressive diseases. Visna virus, a lentivirus of sheep, persists in cells of the macrophage lineage despite the presence of neutralizing antibodies in the animal. These antibodies are measured by prevention of virus replication in sheep fibroblast cel cultures. In this study we have compared the antiviral properties of the antibodies in sheep fibroblast and macrophage cell cultures, the latter being more relevant to infection in the animal. Using infectivity assays, binding of radiolabeled virus to cell membranes, cellular processing of labeled virus into acid-precipitable and acid-soluble components, and in situ hybridization of viral nucleic acid, we show that the antibodies prevented virus replication in both fibroblasts and macrophages. However, the site of neutralization differed between the two cell types. In fibroblasts, the site of virus neutralization was at the cell membrane, when the antibodies prevented virus attachment. In macrophages, virus incubated with the antibodies was phagocytized rapidly, followed by uncoating of the virions. However, virus RNA was not transcribed. Despite this ability of the antibodies to abort virus replication in macrophages, the kinetics of binding of the antibodies to the virus was much slower than the binding of virus to the macrophages. Therefore, persistent virus replication in immune sheep may be the result of virus spreading from macrophage to macrophage before the agent can be neutralized by antibodies in the plasma.
Lentiviruses are nononcogenic, exogenous retroviruses which cause visna (wasting) and maedi (dyspnea) in sheep (19, 42, 43) , arthritis-encephalitis in goats (6, 7) , infectious anemia in horses (3, 4) , and acquired immune deficiency syndrome in humans (12, 16) . These diseases are characterized by long incubation periods, insidious onset, and slowly progressive clinical courses. Infection is persistent, but only a few hosts ever develop clinical disease (9, 10) . Replication of the virus is restricted in the host (21) , and pathologic responses are immune mediated (2, 8, 37) rather than caused by the direct effects of the virus.
Visna virus causes a productive, lytic infection in cultures of sheep choroid plexus (SCP) fibroblasts (44, 45) . In previously reported studies, we used these cells as indicators for measuring infectivity and specific neutralizing antibodies in studies of infection in sheep (17) . These studies showed that the animals produced small amounts of virus neutralizing antibodies 4 weeks or more after inoculation, but the virus could still be obtained from the animal by cocultivation of peripheral blood leukocytes with the fibroblasts. In some persistently infected sheep, virus in cells coexisted indefinitely with neutralizing antibodies in plasma, whereas in other sheep, nonneutralizable mutant viruses, in addition to the parental virus, were obtained from the peripheral blood leukocytes (30, 31) . This development of antigenic mutants, selected by neutralizing antibodies, represents a unique mechanism for survival of the agent in an immune environment.
Recent studies have shown that the target cells of the virus in the persistently infected animal are monocyte macrophages (34, 36) and not fibroblastic cells. Since macrophages have important roles in immunologically specific defenses as * Corresponding author.
well as the nonspecific defenses of the host, we have reexamined the neutralization of visna virus in sheep to determine whether the macrophage target cell may have a role in the ability of the virus to persist in the animal in the face of neutralizing antibodies. Using plaque-purified, cellfree visna virus, serum from a sheep hyperimmunized with visna virus, and fibroblast and macrophage cell cultures, we show here that antibodies to the virus were effective in neutralization, irrespective of the target cell. However, the site of neutralization differed in the two cell types. Neutralization occurred at the cell surface of fibroblasts and intracellularly in macrophages. Surprisingly, however, the virus had a greater affinity for macrophage target cells than did antibodies for the virus. This may thus provide a mechanism for the ability of these agents to replicate persistently in the immune host whether or not antigenic drift in the virus occurs.
MATERIALS AND METHODS
Cell cultures. SCP fibroblasts were derived from early subcultures of the choroid plexus of a newborn, colostrumdeprived lamb. The cells were grown in minimum essential medium (MEM) plus 10% fetal bovine serum and maintained in MEM plus 1 or 2% lamb serum heated for 30 min at 56°C as previously described (33) .
Sheep alveolar macrophages immortalized with simian virus 40 were used in this study. The establishment and characterization of the cell line (transformed macrophages, TM) was reported previously (14) . The macrophages were cultivated as confluent monolayers in Dulbecco MEM (DMEM) supplemented with 20% lamb serum and were maintained in DMEM plus 2% lamb serum. The cells were shown to be macrophages by phagocytic properties, pres-38 KENNEDY-STOSKOPF AND NARAYAN ence of Fc receptors, presence of nonspecific esterases, and ultrastructural morphology. Infection of these macrophages with different strains of lentiviruses resulted in productive virus replication for all strains (14) .
Virus. Icelandic visna virus strains 1514 was used throughout the study (39) . The virus was plaque purified in SCP cell cultures as described previously (32) . In this study infectivity was measured by plaque formation or quantal assays in SCP cultures. The methods were interchangeable because 1 PFU was equivalent to one 50% tissue culture infectious dose (TCID50).
Radiolabeled virus. SCP fibroblast cultures in tissue culture flasks (150 cm2) were infected with virus 1514 at a multiplicity of 0.1. When 50% of the monolayer showed cytopathic effect (CPE), the cells were washed with Hanks balanced salt solution, and 0.25 mCi of [35S]methionine (1,000 Ci/mmol; Amersham Corp., Arlington Heights, Ill.) in 5 ml of methionine-free MEM was added. The flasks were rocked overnight at 37°C in 5% CO2. The medium was then removed and stored at 4°C, and 10 ml of methionine-free medium was added to the cultures. The medium was changed at 4-to 6-h intervals twice, and the supernatant fluids were stored at 4°C. The cultures were then relabeled with isotope overnight as described above, and the medium was removed and pooled with the other supernatant fluids at 40C.
The pooled, labeled virus supernatants were clarified at 1,500 x g for 20 min at 40C and centrifuged at 18,500 x g for 2 h at 4°C. The labeled virus pellets were suspended in NET buffer (50 mM NaCl, 5 mM EDTA, 10 mM Tris hydrochloride, pH 7.4) and added to a step gradient of 5 ml of 55% (wt/wt) sucrose and 7 ml of 20% (wt/wt) sucrose which was centrifuged at 40,000 x g for 2 h at 4°C in a vertical rotor. The virus was collected at the interface of the two sucrose solutions and dialyzed against NET plus 1% lamb serum in a microconcentrator (Centricon; Amicon, Danvers, Mass.).
The labeled virus preparation was divided into 100-pI samples and stored at -700C. The infectivity of the preparation was determined by assay in monolayer cultures of SCP cells as previously described (32) . The amount of radioactivity in the labeled virus preparation was determined in a liquid scintillation counter to determine the ratio of counts per minute in infectious units (cpm/TCID50).
Immune serum. A purified virus suspension containing approximately 108 TCID50 of strain 1514 was treated with Nonidet P-40 detergent at a final concentration of 0.5%. A 2-ml volume of this material was emulsified in 2 ml of complete Freund adjuvant and injected intradermally into four sites of a sheep. Three similar injections of virus antigen emulsified in incomplete adjuvant were given sequentially 2 to 3 weeks apart and followed by two intravenous injections, 1 week apart, of 5 ml of pure antigen. The sheep was bled for serum 7 days after the last injection (30 Probe with a specific activity of 4 x 108 to 6 x 108 cpm/,g was applied to cytocentrifuged preparations in hybridization protocols designed to detect either viral DNA or RNA after autoradiography (20, 28a) .
RESULTS
Virus assay. The purified, [35S]methionine-labeled virus 1514 preparation had an infectivity titer of 108 TCID50/ml.
Comparison of the initial radioactivity with the infectivity showed a ratio of 0.5 cpm/PFU.
Neutralization of virus 1514 by immune serum in SCP and TM cultures. The highest dilution of the immune serum which protected SCP cells against virus-induced CPE was 1:320. Since the virus did not cause clear-cut CPE in TM cultures, supernatant fluids from these cultures that had been inoculated with mixtures of virus and diluted serum 2 weeks previously were transferred, well for well, to confluent SCP cultures. Here, CPE developed only in the cultures receiving virus plus serum diluted more than 1:320. Thus, the neutralizing capacity of the serum for virus 1514 was similar when measured in SCP or TM cultures.
Neutralization kinetics. Neutralization kinetics was determined to learn the rate at which neutralizing antibodies inactivated virus 1514 infectivity. The immune serum was diluted 1:50 in DMEM, mixed with equal volumes of virus suspension containing 106 PFU, and incubated at 37°C. Samples (1 ml) were removed at regular intervals, diluted 1:100 in DMEM at 4°C, and assayed for residual infectivity in SCP cells. No reduction of viral infectivity occurred during the first 15 min of incubation (Fig. 1) . Ninety-nine percent of viral infectivity was lost after 60 min, and no infectivity was detected after 90 min.
Virus 1514 binding to cells at 37°C. Confluent monolayers of SCP fibroblasts and TM (7 x 105 cells per tissue culture dish) were inoculated with labeled virus in DMEM plus 2% normal lamb serum (multiplicity of infection = 1) at 37°C to determine the rate of binding of virus to the cells. Counts representing nonspecific binding (number of cpm in cultures after addition and immediate removal of inocula followed by three washings) were subtracted from sequential determinations of cell-associated radioactivity. Counts were converted to PFU based on the relation of infectivity to radioactivity, which was adjusted to allow for the decay of the [35S]methionine. Virus began to attach to the cells during the first 5 min of incubation, and by 15 min 4,500 and 8,200 PFU had bound to SCP fibroblasts and TM, respectively (Fig. 1 (Fig. 2A ), but only 6,718 + 569 cpm bound in the presence of immune serum (Fig. 2B) after 24 h at 8°C. Further, approximately 40% of the adsorbed cpm from the virus-control serum mixture was irreversibly bound to the SCP cells, in contrast to 11% of the cpm from the immune serum mixture. Only minimal amounts of acid-soluble radioactivity were detected in the inocula of these cultures, indicating that no virus had penetrated and uncoated at 8°C.
Although preincubation of labeled virus 1514 with neutralizing antibodies effectively inhibited irreversible binding of the virus to SCP cells by 87%, a small number of cpm had become irreversibly bound to the cells. To determine whether the virus would penetrate the cells, the cultures were shifted to 37°C after washing with DMEM. Before the temperature shift in this experiment, an average of 4,038 + 1,853 cpm had adsorbed to the SCP cells, but during the first 15 min of incubation at 37°C, more than 50% of this amount had eluted into the culture medium. Less than 9% of this amount was acid soluble (Fig. 3B) . The number of acidsoluble cpm did not increase significantly in the culture medium during further incubation. In contrast, 50% of the cpm that bound initially to control cultures at 8°C (9,343 ± 3,815 cpm) was present in the culture medium 6 h after the temperature shift, and 44% of this was acid soluble (Fig. 3A) .
Thus, the small amount of virus that bound to the SCP cells in the presence of neutralizing antibodies did not penetrate the cells.
To determine whether the immune serum would prevent virus replication of adsorbed virus, we added labeled virus at a multiplicity of infection of 0.4 to the SCP fibroblasts and incubated the culture at 8°C for 14 h. The cultures were then washed three times with DMEM at 8°C, and 1 ml of medium containing either 2% control serum or 2% immune serum for 90 min at 37°C, and the mixtures were cooled to 8°C and added to dishes of SCP fibroblasts at 8°C. These were incubated for 14 h at 8°C. Inocula were then removed in three consecutive washes with cold medium. Cultures were replenished with maintenance medium and shifted to 37°C. As indicated in the figures, the cultures were examined sequentially for radioactivity that bound and irreversibly bound to the cells and for acid-soluble cpm in the supernatant fluids as indicated in the legend of Fig. 2. J. VIROL. (Fig. 4) . However, the percent of irreversibly bound cpm was higher with the immune serum mixture (39.8%) than with the control mixture (28.2%). To determine whether the enhanced number of radiolabeled irreversibly bound virus in the virusimmune serum mixture penetrated and uncoated, the above experiments were repeated and the cultures were incubated at 8°C for 14 h. An average of 8,000 cpm (8,441 + 3,821 cpm) bound during this period. Cultures were then washed and shifted to 37°C. At 2 h after the shift to 37°C, 50% of the cpm that had adsorbed at 8°C appeared in the culture medium. Sixty percent of this was acid soluble (Fig. 5B) . In contrast, only 40% of the cpm in the supernatant fluids from cultures with normal serum was acid soluble after as long as 4 h of incubation at 37°C (Fig. 5A) . Thus, the immune serum not only enhanced the binding of labeled virus to TM, but also expedited penetration and uncoating of the virus in these cells.
Since the immune serum had prevented replication of infectious virus but nevertheless potentiated binding, penetration, and uncoating of the agent in macrophages, we asked whether the antibody-induced block in replication occurred at the stage of reverse transcription of viral RNA to DNA or at a later stage in the virus life cycle. When cultures of TM inoculated with virus-immune serum mixtures were examined for viral DNA by in situ hybridization 48 h after infection at 37°C, less than one grain per cell was detected. In contrast, cultures inoculated with virus and control serum had an average count of 40 grains per cell. Thus virus neutralization in the macrophage occurred at a stage between uncoating of the virion and transcription of the viral RNA.
Statistics. A three-way analysis of variance was performed to test for significance in the interactions among the three variables: (i) the four different treatments of cells (labeled virus + normal serum; labeled virus + normal serum + trypsin-EDTA; labeled virus + immune serum; labeled virus + immune serum + trypsin-EDTA); (ii) changes in cpm of [35S]methionine-labeled virus 1514 associated with cells at different time intervals; and (iii) replicate experiments on different days. The interactions examined were treatments versus time (i x ii), treatments versus replicates (i x iii), and time versus replicates (ii x iii). The P values were <0.001 for each of the three interactions when determined for experiments involving either cell type. This meant that the three interactions were highly significant and permitted data from replicate experiments to be averaged. Data were graphed as the percent of cpm added which was cell associated.
DISCUSSION
Sheep infected with visna virus develop serum neutralizing antibodies gradually during 2 to 4 weeks after virus inoculation (33) . The antibodies are found almost exclusively among the immunoglobulin Gl molecules, a class of antibodies that binds complement (but not Staphylococcus aureus protein A) (38) . Sheep do not produce detectable amounts of neutralizing immunoglobulin M antibodies to visna virus (38) , although such claims have been reported (28) . Demonstration of specificity of low concentrations of neutralizing antibodies, as found in early immune sera, often requires a degree of purification of the immunoglobulin from serum proteins because undiluted serum from uninfected sheep (and from most other species) causes nonspecific inhibition of replication of the virus in cell cultures. Whereas addition of antiglobulins to virus-antibody mixtures enhances virus neutralization (35) , addition of complement does not affect neutralization, and complement does not confer virusneutralizing properties to dilutions of postinfectious sera in the absence of specific neutralizing immunoglobulin in the serum (24, 33, 35) . Therefore, a role for complement in the neutralization of visna virus may not be critical.
Neutralization of visna virus with postinfectious serum requires prolonged incubation of virus-antibody mixtures (39) . To examine the best possible effects of such antibodies, we used a hyperimmune serum with kinetics of neutralization much faster than those of postinfectious sera to show in this study that the antibodies block replication of the agent in both fibroblasts and macrophages by preventing virus adsorption to the former and by interfering with viral RNA transcription in the latter. Despite the effectiveness of these antibodies in neutralization, binding of antibodies to the virus in the neutralization process was slower than binding of virus to the target cells. Therefore, in the three-way interaction among virus, neutralizing antibodies, and target cells, it is theoretically possible for virus to infect cells in the presence of neutralizing antibodies.
To identify the stage of the virus life cycle interrupted by neutralizing antibodies in fibroblasts and macrophages, it was necessary to establish criteria for measuring adsorption, penetration, and uncoating of the virus and the transcription of viral genome. Labeled virus bound poorly to SCP fibroblasts and TM at 8°C; after 24 h, more than 75% of the added cpm was still present in the inoculum. However, low temperatures are known to inhibit adsorption of other retroviruses to target cells (1) . Nevertheless, this procedure was necessary to prevent endocytosis and processing of the virus.
Shift of the inoculated SCP and TM from 8 to 37°C resulted in a sharp rise in acid-soluble cpm in the medium. This showed that the virions had been endocytosed and proteolytic digestion of the viral proteins had begun. Within 6 h after the shift, approximately 50% of the cpm bound to both cell types was present in the medium. Lack of further production of acid-soluble radioactivity after 6 h at 37°C suggested that virus 1514 which had adsorbed to the cells at 8°C had been endocytosed and uncoated within this period.
Proteolytic enzymes are the agents of choice for removal of viruses adsorbed to cell surfaces (15, 23) , and trypsin has been used in previous studies to assess the binding of retroviruses (1) . In this manner, labeled virus attached to the cell surface could be distinguished from virus which had been endocytosed and thereby protected from the protease. In this study, trypsin failed to remove approximately 50 and 30% of the cpm bound to SCP fibroblasts and TM, respectively, after the inoculated cultures had been incubated at 8°C for 14 h. These counts were considered irreversibly bound and probably represented virus which had fused to the cell surfaces and was no longer susceptible to the enzymatic activity of trypsin. Visna-maedi virus is known to cause cell fusion "from without" when inoculated at high multiplicities (22) , and this fusion process may be an integral part of the replication cycle (5) .
The irreversible binding of labeled virus to SCP fibroblasts was inhibited by more than 80% when the virus was pretreated with immune serum. Neutralizing antibodies therefore inhibited replication of the virus in these cells by preventing binding of the virus to putative cellular receptors. Inhibition of virus attachment is one of the classic explanations of virus neutralization, although this is usually seen under conditions in which excess antibodies are used (27, 41) . It is unlikely that the antiserum used in this study had antibodies in great excess since the serum had a neutralizing titer of only 1:320 and was used at 1:50. The failure of the antibodies to prevent infection after virus had adsorbed to the cell emphasized the transient period of potential effec-tiveness of the antibodies in curtailing replication and showed that after fusion of the virus to the cell surface had occurred, neutralizing antibodies were no longer effective.
In contrast to the effect of neutralizing antibodies on infection of SCP fibroblasts, the antibodies enhanced binding, endocytosis, and uncoating of the virus in macrophages. Since virus replication did not occur in these cells and since virus DNA was not found in the cells by in situ hybridization, the block in the virus life cycle probably occurred at a stage between uncoating of the virion and transcription of the viral RNA. It is possible that these events, mimicking those of the early stages of virus replication, may have been mediated by Fc receptors on the surface of the macrophages. Phagocytosis of immune complexes via these receptors may thus have circumvented antibody inhibition of binding of virus to cellular receptors as seen in the SCP fibroblasts. This will be tested in future experiments using F(ab')2 fragments from the immune serum.
The requirement for prolonged incubation (15 min at 37°C) of virus and antibodies before neutralization occurred suggests that more than one molecule of antibody is necessary to neutralize a virion (25) and that the interaction between neutralizing antibodies and virus particles may be initially reversible (11) . This implies that the affinity of the antibodies for the infectious virion may be low. The unusually slow development of neutralizing antibodies in sheep infected with visna virus (17, 18, 39) and the small amounts (low titers) of these antibodies in the serum after prolonged infection support the concept of low affinity. Such antibodies may be a common response in lentiviral infections, and this may provide an explanation for lack of detectable neutralizing antibodies in goats infected with caprine arthritisencephalitis virus (24, 35) as well as the low amounts of neutralizing antibodies in many humans infected with the acquired immune deficiency syndrome retrovirus (40, 47) .
In view of the strong tropism of the ruminant lentiviruses for cells of the monocyte-macrophage lineage, it is possible that infection in these cells may be the major determinant for persistence of the viruses in the animal. This is supported by the fact that virus persists irrespective of whether the animal fails to develop neutralizing antibodies, as seen in goats infected with caprine arthritis encephalitis virus or in visna virus-infected sheep, which do develop neutralizing antibodies. Despite the susceptibility of visna virus to neutralization in macrophages, the greater affinity of the virus for the cell than of the antibody for the virus would favor spread of the agent in the presence of neutralizing antibodies. This provides a mechanism for the known ability of the virus to persist for years in the presence of neutralizing antibodies (32, 46) . It also offers an explanation for the failure of nonneutralizable mutants of visna virus to replace the neutralizable parental virus in immune sheep in which antigenic drift of the virus had occurred (26) . Thus, the ability of these lentiviruses to induce neutralizing antibodies in natural hosts offers no guarantee of cure of the infection. Similarly, the presence of neutralizing antibodies in the immunized host may not necessarily protect against invading virus because the kinetics of neutralization may be too slow to protect target cells.
